IsoFootprint – Paving the Way To Sustainable Isotope Analysis
Now, more than ever, we need to take responsibility for our actions. As global levels of atmospheric carbon dioxide continue to increase, we need to be making positive steps forward to reduce our emissions and remove carbon dioxide from the atmosphere.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors
Present diagnostic procedures and therapeutic strategies solid tumours rely on the detection and targeting of specific marker molecules to classify the tumour and to design an efficient therapy.
Selection of Label-free Cellular Imaging Applications for their Integration in the Screening Strategy
Gerardo Turcatti, Ecole Polytechnique Federale De Lausanne, speaking at Screening Europe 2015.
Fragment-based Approach to Multi-target Compounds
The presented work deals with the development of a fragment based strategy for dual-target drug discovery.
A Structured Approach to Academic Drug Discovery
Simon Ward, University of Sussex, speaking at Discovery Chemistry Congress 2015
Tissue and cfDNA Rare Alleles How Low Can We Go
Seth Crosby, Washington University School of Medicine, discusses both bench and informatic methods used to increase specificity in the apprehension of rare cfDNA alleles.
Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test
Jeff Cummings presents a worked example of circulating tumour cell enumeration as a prognostic/predictive biomarker in cancer research.
New Metabolomics Biomarker for Heart Failure
Metabolomics has been successfully applied to identify and validate biomarkers for congestive heart failure. Diagnosis and risk stratification of heart failure (HF) is challenging.
Continuous Flow Synthesis: Laboratory Approach & Protocol for Scale-up
Amol Kulkarni, National Chemical Laboratory, speaking at Flow Chemistry India.
Exploring Protein-protein Interactions Using Scaffolded and Assembled Peptides as Synthetic Binding Site Mimics
Jutta Eichler, University of Erlangen-Nuremberg, speaking at Discovery Chemistry Congress 2015.
Choosing & Using Fragments in the Generation of Selective Kinase Inhibitors
There is often a debate about just how useful fragments are for well-established conventional targets such as protein kinases. Fragment screening however can be extremely valuable, providing critical ideas that lead to novelty, demonstrating how to achieve selectivity, helping dissect and make the most of HTS and literature compounds, alongside maximising ligand efficiency.